PresentationHello, and welcome to the Hub Group Preliminary Fourth Quarter and Full Year 2025 Results Conference Call. It is now my pleasure to turn the call over to the company. You may now begin.Unknown Executive Hello, and welcome to the Hub Group Preliminary Fourth Quarter and Full Year 2025 Results Conference Call. Joining on the call are Phil Yeager, Hub Group's President, Chief Executive Officer and Vice Chairman; and Kevin Beth, Chief Financial Officer and Treasurer. Statements made on this call th ...

An informational overview of reported February 2026 developments, FDA-approved vs. compounded medication distinctions, Wegovy pill category context, published pricing disclosures, telehealth eligibility considerations, and regulatory factors consumers are researching before choosing a GLP-1 weight loss providerSan Francisco, California, Feb. 05, 2026 (GLOBE NEWSWIRE) -- Disclaimer: This article is for informational purposes only. It is not medical advice. Weight management concerns should be evaluated by a ...

Jeffrey Epstein coordinated the creation of a legal vehicle in 2014 that allowed billionaire financiers Ronald Lauder and Leon Black to share ownership of a $25 million painting, a deal that sheds new light on the extent of the convicted sex offender’s connections to wealth and power.Black’s association with Epstein has been publicly known for years. And the trove of emails released by the Department of Justice last week reveals Epstein’s association with Lauder, an heir to the Estée Lauder cosmetics empire ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

LOS ANGELES--(BUSINESS WIRE)---- $MREO--MREO Investors Have Opportunity to Lead Mereo BioPharma Group plc Securities Fraud Lawsuit with the Schall Law Firm. ...

Affirm’s fiscal second quarter illustrated how buy now, pay later is becoming embedded in routine commerce, where paying over time was once reserved for occasional large purchases.By completing this form, you agree to receive marketing communications from PYMNTS and to the sharing of your information with our sponsor, if applicable, in accordance with our Privacy Policy and Terms and Conditions .Complete the form to unlock this article and enjoy unlimited free access to all PYMNTS content — no additional lo ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Encompass Health reported revenue of $1.54 billion for the quarter ended December 2025, reflecting a year-over-year increase of 9.9% [1] - The earnings per share (EPS) for the quarter was $1.46, up from $1.17 in the same quarter last year, indicating a significant improvement [1] - The revenue exceeded the Zacks Consensus Estimate by 0.23%, while the EPS surpassed the consensus estimate by 12.95% [1] Financial Performance Metrics - Net patient revenue per discharge was reported at $22,273, which was higher than the estimated $22,062.08 [4] - The total number of discharges was 67,238, slightly below the estimated 67,407 [4] - Net Operating Revenues from inpatient services reached $1.5 billion, exceeding the estimated $1.49 billion, marking a 9.6% increase compared to the previous year [4] Stock Performance - Encompass Health's shares have declined by 10.1% over the past month, contrasting with a 0.5% increase in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 3 (Hold), suggesting it may perform in line with the broader market in the near term [3]

For the quarter ended December 2025, MGM Resorts (MGM) reported revenue of $4.61 billion, up 6% over the same period last year. EPS came in at $1.60, compared to $0.45 in the year-ago quarter.The reported revenue represents a surprise of +3.63% over the Zacks Consensus Estimate of $4.44 billion. With the consensus EPS estimate being $0.64, the EPS surprise was +151.14%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their ...